InvestorsHub Logo
icon url

connor26

06/20/05 9:40 AM

#402309 RE: EYE_ON_WALLST #402304

been watching it but what do you make of this

La Jolla (LJPC )
Lupus
Blocks the overproduction of immune cells that attack the kidneys
Status: Riquent has Fast Track designation, and the FDA issued an "approvable" letter in October, 2004, pending a further clinical trial. However, La Jolla warned on May 31 that it doesn't have the financial resources to continue that additional trial.

icon url

girlfriend

06/20/05 9:44 AM

#402313 RE: EYE_ON_WALLST #402304

LU over $3